Nutex Health Inc. NUTX Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 50.8%+9.9pp | 40.9%+26.9pp | 14%-12.4pp | 26.5%-67.6pp | |
| Operating margin | 31.5%+4.3pp | 27.2%+40.0pp | -12.8%+173pp | -185.4%-231pp | |
| Net margin | 8.1%-2.8pp | 10.9%+29.4pp | -18.5%+175pp | -193.7%-248pp | |
| Returns | |||||
| Return on equity | 30.7%-23.2pp | 53.8%+112pp | -58.2%+345pp | -403.6%— | |
| Return on invested capital | 44%+13.4pp | 30.6%+40.4pp | -9.8%+130pp | -139.3%— | |
| Efficiency | |||||
| Asset turnover | 1.1×+0.2× | 0.9×+0.3× | 0.6×+0.1× | 0.5×-0.7× | |
| Liquidity | |||||
| Current ratio | 3.4×+1.5× | 1.9×+0.3× | 1.6×-0.2× | 1.8×-2.3× | |
| Leverage | |||||
| Debt-to-equity | 1.1×-1.5× | 2.5×-1.9× | 4.4×+1.5× | 2.9×+1.4× | |
| Net debt / EBITDA | 0.6×-1.4× | 2×— | —— | —— | |
| Valuation | |||||
| Market capitalization | $1.02B+60.5% | $172.3M+42.7% | $120.74M-90.2% | $1.23B-49.6% | |
| Price / earnings | 10.5×+2.0× | 3.3×— | —— | —— | |
| Price / sales | 1.2×+0.1× | 0.4×-0.1× | 0.5×-5.1× | 5.6×-4.3× | |
| Price / book | 2.9×-0.3× | 1.3×-0.7× | 2×-10.9× | 12.9×-8.5× | |
| EV / EBITDA | 3.9×0.0× | 3.1×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Nutex Health Inc.'s profit margins?
- Nutex Health Inc. (NUTX) runs a 47.5% gross margin and a 31.4% operating margin, with a 11.0% net margin.
- Where do Nutex Health Inc.'s ratios come from?
- Every ratio is computed from Nutex Health Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
